| Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the … C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ... Journal of extracellular vesicles 7 (1), 1535750, 2018 | 8245 | 2018 |
| Biological properties of extracellular vesicles and their physiological functions M Yáñez-Mó, PRM Siljander, Z Andreu, A Bedina Zavec, FE Borràs, ... Journal of extracellular vesicles 4 (1), 27066, 2015 | 4978 | 2015 |
| Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies S O'Neill, L O'Driscoll Obesity reviews 16 (1), 1-12, 2015 | 1798 | 2015 |
| Three-dimensional cell culture: the missing link in drug discovery S Breslin, L O’Driscoll Drug discovery today 18 (5-6), 240-249, 2013 | 1485 | 2013 |
| Applying extracellular vesicles based therapeutics in clinical trials–an ISEV position paper T Lener, M Gimona, L Aigner, V Börger, E Buzas, G Camussi, N Chaput, ... Journal of extracellular vesicles 4 (1), 30087, 2015 | 1185 | 2015 |
| EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research J Van Deun, P Mestdagh, P Agostinis, Ö Akay, S Anand, J Anckaert, ... Nature methods 14 (3), 228-232, 2017 | 936 | 2017 |
| Matrix metalloproteinase expression and production by alveolar macrophages in emphysema GA Finlay, LR O'DRISCOLL, KJ Russell, EM D'ARCY, JB Masterson, ... American journal of respiratory and critical care medicine 156 (1), 240-247, 1997 | 598 | 1997 |
| Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes C Corcoran, S Rani, K O’Brien, A O’Neill, M Prencipe, R Sheikh, G Webb, ... PloS one 7 (12), e50999, 2012 | 493 | 2012 |
| Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine S Fais, L O’Driscoll, FE Borras, E Buzas, G Camussi, F Cappello, ... American Chemical Society, 2016 | 467 | 2016 |
| Inhibiting extracellular vesicles formation and release: a review of EV inhibitors M Catalano, L O’Driscoll Journal of extracellular vesicles 9 (1), 1703244, 2020 | 449 | 2020 |
| Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis C Clarke, SF Madden, P Doolan, ST Aherne, H Joyce, L O’driscoll, ... Carcinogenesis 34 (10), 2300-2308, 2013 | 446 | 2013 |
| Prognostic importance of survivin in breast cancer SM Kennedy, L O'Driscoll, R Purcell, N Fitz-Simons, EW McDermott, ... British journal of cancer 88 (7), 1077-1083, 2003 | 406 | 2003 |
| The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance S Breslin, L O'Driscoll Oncotarget 7 (29), 45745, 2016 | 294 | 2016 |
| Intracellular and extracellular microRNAs in breast cancer C Corcoran, AM Friel, MJ Duffy, J Crown, L O'Driscoll Clinical chemistry 57 (1), 18-32, 2011 | 294 | 2011 |
| miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity K O'Brien, MC Lowry, C Corcoran, VG Martinez, M Daly, S Rani, ... Oncotarget 6 (32), 32774, 2015 | 249 | 2015 |
| Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells K O’Brien, S Rani, C Corcoran, R Wallace, L Hughes, AM Friel, ... European journal of cancer 49 (8), 1845-1859, 2013 | 246 | 2013 |
| Extracellular vesicles and anti-cancer drug resistance N Mc Namee, L O'Driscoll Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1870 (2), 123-136, 2018 | 236 | 2018 |
| miR‐34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression C Corcoran, S Rani, L O'Driscoll The Prostate 74 (13), 1320-1334, 2014 | 235 | 2014 |
| Mesenchymal stem cell derived extracellular vesicles for tissue engineering and regenerative medicine applications D Tsiapalis, L O’Driscoll Cells 9 (4), 991, 2020 | 220 | 2020 |
| Characterisation and manipulation of docetaxel resistant prostate cancer cell lines AJ O'Neill, M Prencipe, C Dowling, Y Fan, L Mulrane, WM Gallagher, ... Molecular cancer 10, 1-13, 2011 | 220 | 2011 |
Claire CorcoranSenior Scientist, AstraZenecaVerified email at tcd.ie
